Center for Financial Planning Inc. purchased a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the 4th quarter, HoldingsChannel reports. The firm purchased 136 shares of the semiconductor company’s stock, valued at approximately $66,000.
Several other institutional investors also recently added to or reduced their stakes in the business. Hazlett Burt & Watson Inc. increased its position in Synopsys by 40.0% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after buying an additional 20 shares during the period. Caprock Group LLC increased its position in Synopsys by 0.5% in the 4th quarter. Caprock Group LLC now owns 3,714 shares of the semiconductor company’s stock worth $1,803,000 after buying an additional 20 shares during the period. Compagnie Lombard Odier SCmA increased its position in Synopsys by 1.1% in the 4th quarter. Compagnie Lombard Odier SCmA now owns 1,850 shares of the semiconductor company’s stock worth $898,000 after buying an additional 20 shares during the period. Aptus Capital Advisors LLC increased its position in Synopsys by 1.5% in the 3rd quarter. Aptus Capital Advisors LLC now owns 1,447 shares of the semiconductor company’s stock worth $733,000 after buying an additional 22 shares during the period. Finally, Resurgent Financial Advisors LLC increased its position in Synopsys by 2.8% in the 3rd quarter. Resurgent Financial Advisors LLC now owns 809 shares of the semiconductor company’s stock worth $410,000 after buying an additional 22 shares during the period. 85.47% of the stock is owned by institutional investors.
Synopsys Price Performance
Shares of SNPS stock opened at $522.53 on Friday. The stock’s fifty day simple moving average is $510.67 and its 200 day simple moving average is $518.23. The firm has a market cap of $80.77 billion, a price-to-earnings ratio of 35.99, a P/E/G ratio of 3.49 and a beta of 1.12. Synopsys, Inc. has a one year low of $457.52 and a one year high of $629.38.
Wall Street Analyst Weigh In
Read Our Latest Stock Report on Synopsys
Insider Activity at Synopsys
In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the business’s stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total value of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares of the company’s stock, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.66% of the stock is owned by insiders.
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- How to Plot Fibonacci Price Inflection Levels
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Why Are These Companies Considered Blue Chips?
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- How to Short Nasdaq: An Easy-to-Follow Guide
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.